人类牛奶寡糖的最新进展及其抗病毒功效
Yihan Chen1, Zhengxin Chen2, Yingying Zhu1
1State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China.
Journal of agricultural and food chemistry
|April 2, 2024
概括
人母奶的寡糖 (HMO) 可以提高婴儿对胃肠道病毒的抵抗力. 本综述探讨了针对轮状病毒和诺罗病毒等病毒的HMO机制,有助于新疗法开发.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 胃肠道 (GI) 病毒,如轮状病毒和诺罗病毒,会引起婴儿的重大疾病.
- 人类牛奶寡糖 (HMO) 影响婴儿肠道微生物群和免疫力.
- HMO显示出增强宿主对GI病毒的耐药性的潜力,但机制需要系统审查.
研究的目的:
- 系统地审查乳糖和中性核心HMO对抗肠道关联病毒的抗病毒作用和机制.
- 阐明HMO结构如何促进宿主对病毒感染的防御.
- 确定HMO或其衍生物的潜在治疗应用.
主要方法:
- 对研究HMO及其与胃肠道病毒相互作用的研究的文献综述.
- 对HMO结构的分析,包括乳糖和中性核类型.
- 检查HMO对病毒结合,复制和宿主免疫反应的影响的证据.
主要成果:
- HMO对各种胃肠道病毒,包括轮状病毒和诺病毒,表现出多样化的抗病毒作用.
- 特定的HMO结构显示出不同的结合亲和力和针对不同病毒的抑制机制.
- HMO可以调节肠道微生物群的组成,间接地对抗病毒防御做出贡献.
结论:
- 胃肠道组织为预防和治疗婴儿胃肠道病毒感染提供了一个有希望的策略.
- 了解HMO-病毒相互作用对于开发基于HMO的新疗法至关重要.
- 对HMO衍生物的进一步研究可能会导致病毒性胃肠炎和相关并发症的先进治疗方法.
相关概念视频
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Bacteriophages of the Human Virome
Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


